Trials / Unknown
UnknownNCT04770857
Evaluation of Post-ERCP Pain as a Predictor for Post-ERCP Pancreatitis
Evaluation of Post-Post-Endoscopic Retrograde Cholangiopancreaticography Pain (ERCP) as a Predictor for Post-ERCP Pancreatitis
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Nicola Frei · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Pancreatitis is the most common complication after ERCP, although its frequency varies significantly depending on the study from \< 2% up to 40%. Based upon data from studies that have included unselected patients, post-ercp pancreatitis (PEP) is mild, moderate, and severe in 45%, 44%, and 11% of cases, respectively. Dysfunction of the sphincter Oddi, female gender, younger age, previous history of pancreatitis, prolonged procedure time and pancreatic guidewire passages are well-known independent risk factors for PEP. This study will assess whether the development of PEP can be predicted by Visual analogue scale (VAS) level 1 hour after ERCP.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Visual analogue scale | Post procedural pain assessment using the visual analogue scale (VAS) will be performed in patients undergoing ERCP |
Timeline
- Start date
- 2021-09-01
- Primary completion
- 2023-05-01
- Completion
- 2023-08-01
- First posted
- 2021-02-25
- Last updated
- 2021-07-29
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT04770857. Inclusion in this directory is not an endorsement.